ALTEROLA BIOTECH INC by Alterola Biotech, Inc. Financials - Benzinga

ALTEROLA BIOTECH INC by Alterola Biotech, Inc.

ABTIOTCEM

Trade with Public

Trade with Public

$0.00020

N/A

At close: Aug 31, 5:00 PM EST

Overview NewsFinancialsSentiment Compare

ALTEROLA BIOTECH INC by Alterola Biotech, Inc. Financials

ALTEROLA BIOTECH INC by Alterola Biotech, Inc. (ABTI) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Bright Green Announces Q4 2022 Financial Update; As of December 31, 2022, Bright Green Had Cash Of $414,574

Continued investment to support long-term strategy and pathway for growth, including plans to fully acquire Alterola Biotech, appointment of Seamus McAuley as Chief Executive Officer and expansion of Scientific Advisory

Happy Mohamed